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Fibromyalgia (FM) is a kind of nonarticular rheumatism 
(Arnold, 2010; Arnold, Hudson, Hess, Ware, Fritz, & Auchenbach, 
2004; Arnold, Hudson, Keck, Auchenbach, Javaras, & Hess, 2006; 
Ballina, 2004) that is characterized by chronic musculo-skeletal 
pain associated with painful palpation certain predetermined sites 
(Casanueva, 2007). The pathogenic mechanisms that provoke the 
symptoms in these patients are currently unknown, and no objective 
alterations in the structures where the pain is located, in the muscles 
or the adjacent nervous paths have been found (Bennett, Clark, & 
Campbell, 1991). There is evidence supporting the participation 
of undefi ned anomalous psychophysiological processes (Dailey, 
Bishop, Russell, & Fletcher, 1990; Goldenberg, 2010; Uveges, 
Parker, & Smarr, 1990), which increases the confusion of the 
clinical approach to this highly prevalent disease (Pastor, Lledó, 
López-Roig, Pons, & Martín-Aragón, 2010).
One of the most relevant issues is the association of the 
fi bromyalgic syndrome with diverse sleep alterations. Ever since 
the polysomnographic studies of Moldofsky (Moldofsky, Lue, 
& Smythe, 1983; Moldofsky & Scarrisbrick, 1976; Moldofsky, 
Scarrisbrick, England, & Smythe, 1975; Smythe & Moldofsky, 
1977), many works have found evidence that sleep disorders play 
a determinant role in the physiopathology of FM (Carette, Oakson, 
Guimont, & Steriade, 1995). As noted by Yunus and Kalyan-Raman 
(1989), in 80% of patients with FB, nonrestorative, fragmented, 
and superfi cial sleep is observed, which is related to the intensity 
of pain and a feeling of exhaustion. Other kinds of sleep anomalies 
have also been described in patients with FM, such as the increase 
in the number of awakenings (Jennum, Drewers, Andreasen, & 
Nielse, 1993; Sarzi-Puttini et al., 2002), a reduction of the quantity 
of phases III and IV (Sarzi-Puttini et al., 2002), an increase in sleep 
latency and in the number of phase changes per hour, as well as an 
increase in the duration of phase I (Moldofsky, 1997).
One of the most controversial aspects is the existence of a 
specifi c polysomnographic pattern in FM. It has been postulated 
that this could be identifi ed by the presence of an alpha disorder 
of the non-rapid eye movement (NREM) sleep (Branco, Atalia, & 
Paiva, 1994; Moldofsky, 1986; Moldofsky, Tullis, Lue, Quance, 
& Davidson, 1984). A link between FM and the obstructive sleep 
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The main objective of this work was to evaluate the characteristics of sleep in patients diagnosed 
with fi bromyalgia syndrome. Sleep architecture in 32 patients with fi bromyalgia and 20 healthy 
controls was evaluated. Following the recommendations of the International Federation of Clinical 
Neurophysiology, polysomnographies were conducted with fi bromyalgia patients and the control 
subjects. The fi bromyalgia patients showed alterations in cyclic organization of sleep and an increased 
number of periodic leg movements associated with cortical arousals. No signifi cant differences were 
found in respiratory and oximetry variables or in alpha-delta sleep. The results support that fi bromyalgia 
patients present an increase of superfi cial sleep at the expense of deep sleep and also an increase of 
periodic leg movements, which could have a pathogenic effect, facilitating the onset of the illness. 
Lastly, we discuss the results and propose some future lines of research.
Arquitectura del sueño en pacientes con fi bromialgia. El objetivo central del trabajo fue evaluar las 
características del sueño en pacientes con fi bromialgia. Se evaluó la arquitectura del sueño en 32 pacientes 
con fi bromialgia, utilizando  como controles 20  personas sanas. Tanto a las pacientes fi bromiálgicas 
como a los controles se les realizó una polisomnografía de acuerdo con las recomendaciones de la 
Federación Internacional de Neurofi siología Clínica. Las pacientes con fi bromialgia mostraron 
alteraciones en la organización cíclica del sueño, así como mayor número de movimientos periódicos 
de las piernas asociados a despertares corticales. No se han obtenido diferencias signifi cativas en las 
variables respiratorias ni oximétricas, tampoco en el sueño alfa-delta. Los resultados obtenidos indican 
que las pacientes con fi bromialgia presentan incremento del sueño superfi cial en detrimento del sueño 
profundo, así como un  incremento de los movimientos periódicos de las piernas, que podrían actuar de 
forma patogénica, favoreciendo la aparición de la enfermedad. Finalmente, se discuten los resultados y 
se proponen futuras líneas de investigación.
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apnea syndrome has also been described (Donald, Esdaile, Kimoff, 
& Fitzcharles, 1996; May, West, Baker, & Everett, 1993; Molony 
et al., 1986; Sarzi-Puttini et al., 2002); or, lastly, a high incidence of 
Periodic Limb Movements in patients diagnosed with this disease 
(MacFarlane, Shahal, Mously, & Moldofsky, 1996; Tayag-Kier et 
al., 2000). 
Although the conclusion of most of these studies suggests 
the existence of electroencephalographic anomalies in the sleep 
of patients with FM, the association of both processes is not 
acknowledged by all the authors (Horne & Shackell, 1991; Hyyppä 
& Kronholm, 1995). In addition, it is still unclear whether FM is 
originated by these anomalies, or whether FM and sleep alterations 
are both the result of another, as yet unknown, pathogenic factor. 
However, the diversity of the response criteria and of the 
instruments used, in addition to the many variables assessed, have 
not allowed us to defi ne the relation of sleep disorders and FM 
completely. Therefore, all the above-mentioned results should be 
interpreted with caution, as the review of the diverse works on 
the relation of fi bromyalgia with sleep disorders reveals various 
problems, among which are included: (a) an insuffi cient sample 
size in most of the studies (Branco et al., 1994; Horne & Shackell, 
1991); (b) the absence of control groups when conducting the 
studies (Moldofsky et al., 1975; Molony et al., 1986); and (c) the 
absence of standardized recording techniques (Carette et al., 1995; 
Mahowald & Mahowald, 2000). These methodological defi ciencies 
can, to a great extent, explain some of the discrepancies in the 
results obtained to date.
According to the hypothesis that patients with FM present 
sleep alterations that may be involved in their pathogenia, we 
should observe a specifi c pattern when comparing them to the 
control group of healthy population. Along the lines of the 
preceding studies, the goal of this work is to contribute data 
about the probable relation of sleep alterations as an essential 
physiopathological component of FM (Okifuji, Turk, & Sherman, 
2000; Villagrán, Páez, Campo, Pérez, & Salaberri, 2000). We wish 
to determine whether sleep alterations, their structure, the number 
of cortical awakenings, alpha-delta activity, or the respiratory 
function present a characteristic pattern of fi bromyalgia (Pöyhaiä, 
Da Costa, & Fitzcharles, 2001). To achieve this goal, we will 
assess not only fi bromyalgic patients but also healthy controls 
without chronic pain, conducting studies of sleep according to 
the recommendations of the International Federation of Clinical 
Neurophysiology (Deuschl & Eisen, 1999).
Method
Participants 
After the study was approved by the Ethical Committee of the 
Hospital Centro Médico [Medical Center Hospital], and respecting 
the Helsinki Declaration of the World Medical Association in its 
entirety, we recruited a total sample of 32 women, aged between 
28 and 70 years (Mean= 50.1, SD= 10.33), selected consecutively 
from among those who came to the rheumatology consulting 
offi ce, with symptomatology duration of over 2 years, who met 
the diagnostic criteria of the American College of Rheumatology 
(Wolfe, Smythe, & Yunus, 1990) and who agreed to participate, 
signing an informed consent form. Patients with associated diseases 
susceptible of provoking secondary FM and patients who consumed 
medication that could affect their sleep for at least 3 months prior to 
the test were excluded. As control group, we included 20 women, 
aged between 28 and 64 years (M= 44, SD= 10.77) who did not 
present any kind of physical or psychological pathology (sleep 
disorders, rheumatic disease, major psychopathology, multiple 
organic pathology, neoplasia, psychotropic or drug dependency) 
that required medical intervention or medication.
The inclusion criteria, both in the FM group and the control 
group, were confi rmed by expert professionals and ratifi ed by 
the specialized neurophysiologist in charge of conducting the 
polysomnography. All the patients were selected through the 
Rheumatology Service of the Medical Center Hospital of Asturias 
(Spain) and from the Psychology Faculty of the University of 
Oviedo (Spain), and the women used as healthy controls were 
randomly selected from a list of volunteers, also through the 
Medical Center Hospital. No signifi cant differences were observed 
in age, civil status, and educational level among the people from 
the experimental and control groups. 
Sleep polysomnography
Procedure
In all cases (patients and healthy controls), the polysomnographies 
were conducted in similar and standardized conditions, individually, 
in a sleep laboratory of the Medical Center Hospital of Asturias 
(Spain). After two hours preparation, the recordings were initiated 
at 11 o’clock p.m. and concluded at 7 o’clock a.m., thus covering 8 
hours of nocturnal recording in basal conditions. All the recordings 
were carried out with an infrared camera for nocturnal vision.
The recording consisted of monitoring two bipolar EEG 
derivations (Cz-A1 and O1-A1), a bipolar channel for the left 
and right electrooculogram (EOG), and two bipolar channels 
for the electromyogram (EMG), one for the submentonian 
muscle, and the other for the tibialis anterior muscle. Respiratory 
parameters included a channel for nasal-oral air fl ow and a channel 
for abdominal respiratory movements, a bipolar channel for 
electrocardiographic recording, and a channel to record snoring 
and body position. Respiratory activity was recorded by means 
of elastic bands with a piezoelectric sensor that recorded thoracic 
and abdominal movements and a nasal-oral air fl ow sensor. The 
level of oxygen saturation was recorded by means of a pulsiometer 
placed on the index fi nger.  
Instrument 
To conduct the polysomnographies, we used a 32-channel 
Discovery electroencephalograph (Medelec Vickers Medical, 
Inc.) 
Interpretation of the polysomnographic data
To analyze the polysomnographies, we followed the 
classifi cation system of Rechtschaffen and Kales (1968). The 
diverse sleep phases were recorded manually in 30-second epochs, 
and the successive NREM-REM cycles were recorded taking the 
REM periods into account. The percentages of the sleep phases 
with regard to total sleep time were determined. NREM phases 
III and IV were considered slow-wave sleep. Sleep effi ciency was 
defi ned by the percentage of time in bed used for sleeping, and 
sleep latency by the time it took to initiate sleep.
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Arousals were defi ned according to the ASDA (American Sleep 
Disorders Association) criteria, by abrupt changes in the EEG 
frequencies, with activation of the submentonian EMG or of the 
EOG. Alpha activity was defi ned in a frequency range of 7.0 - 12.0 
Hz., with a minimum peak-to-peak amplitude of 5 μv, and grouped 
in four scales as a function of the percentage of alpha events in the 
NREM phase II and deep sleep phases: 1) 0-25%, 2) 26-50%, 3) 
51-75% and 4) 76-100% (MacLean, Lue, & Moldofksy, 1995). The 
K-alpha phenomenon (micro-arousal) is defi ned by a K-complex 
immediately followed by an explosion of abnormal alpha activity 
lasting less than 5 seconds (Roizenblant, Moldofsky, Benedito-
Silva, & Tufi k, 2001).
Apnea is defi ned as the cessation of airfl ow for 10 seconds or 
more (including the different types: central, obstructive, or mixed). 
Hypoapneas were recorded when a reduction of airfl ow of at least 
50% of the baseline, during at least 10 seconds, was produced. The 
level of oxygen saturation (Sa= 2) obtained at night, which allows 
identifi cation of the severity of the apnea, was also measured. 
Up to 85% of oxygen desaturation is considered mild, up to 75% 
moderate, and lower than 75% is considered severe. A rate of 
apneas/hypoapneas higher than 5 events/hour of sleep is considered 
pathological. Likewise, we defi ned periodic limb movements as the 
onset of sequences of at least four muscular contractions lasting 
0.5 to 5 seconds, with an interval between each twitch of 5 to 90 
seconds (Aldrich, 1996; Thorpy, 1990). When these movements 
provoke fragmentation of sleep architecture, they are associated with 
K-complexes or with alpha activity (cortical micro-awakenings). To 
determine their severity, we used an index that considers the number 
of motor events followed by awakening reaction per hour of sleep, 
and if it was higher than 5, it was considered pathological.
Data analysis
To compare the results obtained in the polysomnography for 
the people of the two groups, we carried out multivariate analysis 
of variance (MANOVA), which yielded global differences. When 
Wilks’ λ was signifi cant (p≤05), univariate analyses of variance 
(ANOVA) was used to determine the variables in which the groups 
differed. We used η² as an effect size index. Values of η²> .15 can 
be considered high, and when η² > .06 , the effect size is moderate. 
All the statistical analyses were conducted with version 15.0 of the 
SSPS program for Windows. 
Table 1








Time in bed (minutes) 408.49 (27.73) 420.59 (20.74) 2.811 .100 .053
Sleep interval (minutes) 377.67 (40.19) 387.96 (27.34) 1.014 .319 .020
Total sleep time (minutes) 327.20 (55.63) 357.31 (41.50) 4.336 .042 .080
Index of sleep effi ciency .853 (.114) .907 (.073) 3.529 .066 .066
Time of wakefulness after sleep onset (minutes) 18.93 (10.45) 8.85 (8.15) 13.460 .001 .212
Number of awakenings 70.31 (47.89) 19.60 (13.06) 21.288 .000 .299
Phase I (%) 7.12 (4.52) 11.82 (18.11) 1.980 .166 .038
Phase II (%) 57.00 (9.48) 48.55 (16.25) 5.628 .022 .101
Phase III (%) 8.92 (4.24) 8.62 (5.30) .350 .557 .007
Phase IV (%) 9.53 (5.48) 13.15 (4.06) 6.435 .014 .114
REM phase (%) 16.552 (6.68) 16.366 (5.23) .011 .916 .000
REM latency (minutes) 129.48 (84.50) 110.45 (61.13) .763 .378 .015
Sleep latency (minutes) 16.96 (16.77) 26.50 (36.62) 1.639 .206 .031
Sleep events
Apneas 3.637 (10.12) .0500 (.223) 2.491 .121 .047
Apnea index .3875 (1.53) .000 (.000) 1.260 .267 .025
Hypoapneas 1.100 (3.84) .000 (.000) 2.178 .146 .042
Hypoapnea index .0962 (.4004) .000 (.000) .926 .340 .018
Apnea + Hypoapnea Index .7094 (2.27) .000 (.000) 1.929 .171 .037
Desaturations > 90% 2.312 (12.72) .000 (.000) .656 .422 .013
Alpha-delta sleep 0-25% 1.561 (3.96) .1500 (.670) 2.469 .122 .047
Alpha-delta sleep 26-50% 1.146 (3.45) .0500 (.223) 1.922 .164 .038
Alpha-delta sleep 51-75% .6047 (2.83) .000 (.000) .902 .347 .018
Alpha-delta sleep 76-100% .2546 (1.41) .000 (.000) .644 .426 .013
Limb movements 17.781 (19.81) 7.050 (6.35) 5.477 .023 .099
Limb movements+awakenings 41.838 (46.58) 4.400 (3.76) 12.772 .001 .203
Index of limb movements 11.115 (10.80) 2.378 (2.55) 12.554 .001 .199
K+awakenings 17.05 (13.27) 8.660 (5.08) 7.283 .009 .127
p≤0,05
Wilks value= 3.535; p= .001
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Results
The summary in Table 1 shows group differences (Wilks’ value: 
F= 3.723, p= .001) in the scores obtained in the polysomnography. 
When analyzing sleep architecture, the neurophysiological study 
showed that the patients with FM presented a decrease in total 
sleep time (F= 4.336, p= .042) in comparison to the healthy 
controls. Fibromyalgic patients also presented an increase in the 
time of wakefulness after sleep onset (F= 13.460, p= .001) and in 
the number of awakenings (F= 21.288, p= .000) as compared with 
healthy controls. 
When comparing the percentages of the diverse NREM sleep 
phases, we observed alterations in the cyclic organization of sleep: 
the percentage of phase II time was higher in the FM group than 
in the control group (F= 5.628, p= .022), whereas in phase IV, the 
opposite pattern was observed, that is, the percentage of phase II 
time was lower in the FB patients than in the control group (F= 
6.435, p=.014). 
Upon analysis of the diverse sleep events, no signifi cant 
differences were obtained either in the respiratory variables, 
the oxymetric variables, or in alpha-delta sleep. In contrast, we 
observed differences between the FM patients and the control 
group in myoclonic movements. Spontaneous limb movements 
occurred at intervals during sleep and especially during NREM 
sleep (Moldofsky et al., 1984). We observed that the FM group 
presented a higher number of periodic limb movements (F= 
5.477, p= .023) and of periodic limb movements associated with 
cortical awakenings (F= 12.772, p= .023). The FM group also 
presented a higher rate of limb movements (F= 12.554, p= .001) 
and of K-complex + awakenings, characteristic of superfi cial sleep 
phases (F= 7.267, p= .010).  
Discussion and conclusions
After decades of research, we have not yet identifi ed the 
pathogenic mechanisms that provoke pain in fi bromyalgia. There 
is evidence of the existence of anomalous psychophysiological 
processes in the origin of fi bromyalgia (Dailey et al., 1990; Uveges 
et al., 1990). In this sense, alterations at multiple levels, both in the 
afferent transmission of the signal and in the efferent responses 
produced as mechanisms to modulate pain, have been observed. 
Multiple neurotransmitters and regions have been implicated to 
date in the anomalous processing of pain in patients with FB, in an 
attempt to establish the physiopathological mechanisms that could 
explain the hyperpathia produced in practically all these patients 
(Ablin, Buskila, & Clauw, 2009; Williams & Clauw, 2009).
Most patients with FB present sleep alterations (Carette et al., 
1995; Jacobsen, Petersen, & Danneskioldsamsoe, 1993; Moldofsky 
et al., 1975; Sergi et al., 1999), although whether there is a specifi c 
pattern or whether it is a case of alterations related to coexisting 
processes, such as anxiety disorder or depression, has not been 
established. 
Traditionally, the Alpha-NREM Sleep Disorder has been 
associated with a longer duration of pain and with superfi cial sleep. 
The so-called alpha-delta sleep interferes with the normal function 
of sleep, turning it into nonrestorative sleep and favoring daytime 
fatigue and muscular-skeletal pain more than the presence of 
behavioral changes or shortened sleep do. However, the abnormal 
alpha rhythm could refl ect a state of alertness during nocturnal sleep 
that would determine the subjective feeling of nonrestorative sleep. 
In comparison to the fi ndings of previous studies (Roinzenblatt, 
Moldofsky, Benedito-Silva, & Tufi k, 2001), the results obtained 
in the present study do not allow us to establish an association 
between alpha-delta abnormalities and FB, in comparison to the 
control group. Thus, although patients with FB present poor sleep 
quality, with more transactional sleep and high fragmentation, 
they do not differ from the control participants in the alpha-delta 
rhythm (Shaver et al., 1997), despite the signifi cant reduction in 
slow-wave sleep. 
The comparison of the results obtained with patients with FB 
confi rms that the alpha-delta alterations of their sleep are not easy 
to explain; the existence of possible methodological differences in 
the selection of the patients or in sleep recording could contribute 
to these divergent results (Branco et al., 1994). These discrepancies 
could be due to the fact that alpha-delta sleep might be considered 
a sleep alteration that would involve partial alertness, typical of 
sleep apnea or of the syndrome of periodic limb movements while 
sleeping and, therefore, it would not be an intrinsic characteristic 
of FB (Branco et al., 1994; Shaver et al., 1997). 
Periodic limb movements, a specifi c sleep disorder that is 
responsible for diffi culties to initiate and maintain sleep and 
for excessive daytime somnolence, is also one of the intrinsic 
alterations that determine the fragmented sleep of patients with FB. 
These stereotyped movements of the legs are followed by partial 
arousals or awakenings that interrupt the continuity of sleep. In 
patients with FM, it has been postulated that this type of alterations 
is not necessarily associated with abnormal alpha-delta activity 
(Moldofsky, 1986; Moldofsky, Tullis, Lue, Quance, & Davidson, 
1984). However, in accordance with the hypothesis proposed in 
the present study, we verifi ed that the FB patients present a higher 
number of periodic limb movements, and their association with 
K-complexes, characteristic of superfi cial NREM sleep. These 
periodic movements (Coleman, Pollack, & Weitzman, 1980) could 
be the refl ection of an unspecifi c disorder that provokes cortical 
awakenings and would respond to a chronic alteration of the 
circadian functioning of sleep-wakefulness occurring in patients 
with FB. Moreover, these motor events could be responsible 
for the frequent micro-awakenings found and, therefore, affect 
sleep continuity and provoke fragmentation of its architecture, 
increasing superfi cial sleep (NREM phase II) at the cost of deep 
sleep (NREM phase IV) in patients with FB (Horne & Shackell, 
1991), determining a decrease in the total sleep time with a high 
number of awakenings. 
The present study has some limitations that should be 
commented on. Firstly, it used a small sample, which does not 
allow us to reach defi nite conclusions, although the differences 
between the groups examined are suffi ciently signifi cant. The 
control group was selected with rigor, discarding patients with 
diseases that could provoke chronic pain or sleep alterations. 
This could introduce biases because, given the high prevalence 
of chronic pain or of primary or secondary sleep alterations in 
this age range in the female population, we may have selected 
an exceptionally «healthy» cohort that does not represent the 
truly normal population. In future studies, additional comparison 
groups should be included, with other causes of chronic pain and 
insomnia, in an attempt to defi ne specifi c patterns of alteration in 
FB. Moreover, in view of the infl uence that the body mass index 
can have on the results of polysomnography, in the future, this 
measurement should be included, and excess of a certain defi ned 
threshold should be used as an exclusion criterion. 
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Summing up, the results obtained partially support the 
hypothesis that alterations in the cyclic organization of sleep 
(with decrease of total sleep time and increase of superfi cial sleep 
in detriment of deep sleep) in patients with FM could play an 
essential physiopathological role and could be a pathogenic factor 
for the development of this disease. However, neither respiratory 
anomalies (without oxygen desaturations) nor anomalies in alpha-
delta sleep were detected, despite a higher percentage of superfi cial 
sleep. The increase of periodic limb movements (associated with 
cortical awakenings) in patients with FM could be involved in the 
feeling of nonrestorative sleep, and thus predict the development 
of diffuse chronic pain. With a view to the future, it would be very 
interesting to use larger samples of patients and samples of people 
with other diseases that present chronic pain, which would allow 
us to determine whether FM presents a specifi c sleep pattern and 
thus, improve the therapeutic approach to FM.
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